Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1960;22:184-190

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RICHARDSON, D. W.
Right arrow Articles by CAVELL, G. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by RICHARDSON, D. W.
Right arrow Articles by CAVELL, G. C.

(Circulation. 1960;22:184.)
© 1960 American Heart Association, Inc.


Circulatory Effects of Guanethidine

Clinical, Renal, and Cardiac Responses to Treatment with a Novel Antihypertensive Drug

D. W. RICHARDSON M.D.1; E. M. WYSO M.D.1; J. H. MAGEE M.D.1; G. C. CAVELL M.D.1

1 From the Medical Service, Veterans Administration Hospital, and the Department of Medicine, Medical College of Virginia, Richmond, Va.

Guanethidine, a new synthetic hypotensive drug that probably interferes with release of norepinephrine from sympathetic nerve endings and that does not inhibit parasympathetic activity, has proved an effective agent in reducing blood pressure in 25 hypertensive patients studied for periods up to 6 months. Untoward effects have been limited to orthostatic hypotension and mild diarrhea.

The drug apparently lowers blood pressure by reduction in cardiac output rather than by relaxation of the arterioles. Reduction in renal blood flow and glomerular filtration rate accompanied administration of the drug, but in no case did progressive azotemia or oliguria occur.

This agent is an extremely potent hypotensive drug with a remarkably prolonged duration of action and with none of the parasympatholytic side effects produced by ganglionic-blocking agents.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
A. D. Bender
The Hemodynamics of Hypertension and Anti Hypertensive Therapy
Angiology, September 1, 1966; 17(9): 627 - 639.
[PDF]


Home page
ANGIOLOGYHome page
A. A. Rubin
Hemodynamic Aspects of Certain Antihypertensive Agents
Angiology, February 1, 1963; 14(2): 74 - 78.
[PDF]


Home page
ANGIOLOGYHome page
M. J. Kert, A. M. Dashe, R. H. Mailman, S. I. Roth, and A. Zager
A Long-Term Study of Combined Guanethidine and Hydrochlorothiazide Therapy in the Management of Hypertension
Angiology, November 1, 1962; 13(11): 511 - 519.
[PDF]